415 related articles for article (PubMed ID: 14524636)
1. Update on the National Cholesterol Education Program Adult Treatment Panel III guidelines: getting to goal.
McKenney JM
Pharmacotherapy; 2003 Sep; 23(9 Pt 2):26S-33S. PubMed ID: 14524636
[TBL] [Abstract][Full Text] [Related]
2. New features of the National Cholesterol Education Program Adult Treatment Panel III lipid-lowering guidelines.
Brewer HB
Clin Cardiol; 2003 Apr; 26(4 Suppl 3):III19-24. PubMed ID: 12708635
[TBL] [Abstract][Full Text] [Related]
3. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
Bersot TP; Pépin GM; Mahley RW
Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
[TBL] [Abstract][Full Text] [Related]
4. Update on the management of dyslipidemia.
Irons BK; Snella KA; McCall K; MacLaughlin EJ; Villarreal M
Am J Health Syst Pharm; 2002 Sep; 59(17):1615-25. PubMed ID: 12224342
[TBL] [Abstract][Full Text] [Related]
5. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
Evans M; Roberts A; Davies S; Rees A
Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
[TBL] [Abstract][Full Text] [Related]
6. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
[TBL] [Abstract][Full Text] [Related]
7. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic implications of recent ATP III guidelines and the important role of combination therapy in total dyslipidemia management.
Boden WE
Curr Opin Cardiol; 2003 Jul; 18(4):278-85. PubMed ID: 12858126
[TBL] [Abstract][Full Text] [Related]
9. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; ; ;
Circulation; 2004 Jul; 110(2):227-39. PubMed ID: 15249516
[TBL] [Abstract][Full Text] [Related]
10. Attainment of normal lipid levels among patients on lipid-modifying therapy in Hong Kong.
Ambegaonkar B; Chirovsky D; Tse HF; Lau YK; Tomlinson B; Li SK; Yue CS; Wong TH; Choi MC; Tunggal P; Sazonov V
Adv Ther; 2012 May; 29(5):427-41. PubMed ID: 22562782
[TBL] [Abstract][Full Text] [Related]
11. Role of the National Cholesterol Education Program Adult treatment panel III guidelines in managing dyslipidemia.
Talbert RL;
Am J Health Syst Pharm; 2003 Jul; 60(13 Suppl 2):S3-8; quiz S25. PubMed ID: 12901024
[TBL] [Abstract][Full Text] [Related]
12. Managing dyslipidemia in the high-risk patient.
Stein EA
Am J Cardiol; 2002 Mar; 89(5A):50C-57C. PubMed ID: 11900720
[TBL] [Abstract][Full Text] [Related]
13. Management of dyslipidemia in the metabolic syndrome: recommendations of the Spanish HDL-Forum.
Ascaso J; Gonzalez Santos P; Hernandez Mijares A; Mangas Rojas A; Masana L; Millan J; Pallardo LF; Pedro-Botet J; Perez Jimenez F; Pintó X; Plaza I; Rubiés J; Zúñiga M
Am J Cardiovasc Drugs; 2007; 7(1):39-58. PubMed ID: 17355165
[TBL] [Abstract][Full Text] [Related]
14. New therapeutic options in the National Cholesterol Education Program Adult Treatment Panel III.
Talbert RL
Am J Manag Care; 2002 Sep; 8(12 Suppl):S301-7. PubMed ID: 12240701
[TBL] [Abstract][Full Text] [Related]
15. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.
Isles CG; Paterson JR
QJM; 2000 Sep; 93(9):567-74. PubMed ID: 10984551
[TBL] [Abstract][Full Text] [Related]
16. Achievement of optimal combined lipid values in a managed care setting: is a new treatment paradigm needed?
Sarawate CA; Cziraky MJ; Stanek EJ; Willey VJ; Corbelli JC; Charland SL
Clin Ther; 2007 Jan; 29(1):196-209. PubMed ID: 17379061
[TBL] [Abstract][Full Text] [Related]
17. Management of hypercholesterolaemia in postmenopausal women.
Davidson MH; Maki KC; Karp SK; Ingram KA
Drugs Aging; 2002; 19(3):169-78. PubMed ID: 12027776
[TBL] [Abstract][Full Text] [Related]
18. An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program.
Ansell BJ; Watson KE; Fogelman AM
JAMA; 1999 Dec; 282(21):2051-7. PubMed ID: 10591388
[TBL] [Abstract][Full Text] [Related]
19. Lipid and nonlipid benefits of statins.
Chilton RJ
J Am Osteopath Assoc; 2003 Jul; 103(7 Suppl 3):S12-7. PubMed ID: 12884939
[TBL] [Abstract][Full Text] [Related]
20. HDL and triglyceride as therapeutic targets.
Fruchart JC; Duriez P
Curr Opin Lipidol; 2002 Dec; 13(6):605-16. PubMed ID: 12441884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
